Hepatic IRS-2 mRNA was significantly lower in SS and NASH patients than in controls, while hepatic PEPCK and G6Pase mRNA levels in the SS and NASH patients were significantly higher than those in the control group. Here, IRS2 is linked to metabolic dysfunction-associated steatohepatitis.